Good MorningEquity markets retreat on Wednesday on a double dose of bad news. On the earnings front, better-than-expected earnings are offset by weak guidance, while on the economic front, the yield on the 10-year treasury rose to another new high. The 10-year rise suggests the FOMC will continue to hike rates to near 5.0% in its fight against inflation. The Fed needs to see a significant decline in demand to ensure inflation is tamed, which has yet to be seen in the data.
The S&P 500 fell more than 1.25% at the session's low, showing persistent resistance at the short-term 30-day EMA. If that level can't be crossed, the market will likely fall. The decline could build significant momentum if the guidance continues to be negative. The S&P 500 could fall back to the recent low or lower in this scenario. Critical support is near 4,224 for the S&P, a move below there could produce another 5% decline for stocks. Featured: Wall Street’s quietly buying these 3 AI infrastructure plays (Ad) 
|
Technology | |
ASML Holding (NASDAQ: ASML) is an excellent buy for AI exposure. It is the only manufacturer of advanced lithography technology to make the world’s most advanced chips. And the rise of AI is not the only driver for this business. The world is expanding its chip-making capabilities, including... Read the Full Story |
|
From Our Partners | | BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one that gets burned with every transaction on what analysts are calling America's new financial grid.
The Nasdaq has received SEC approval to move stocks onto blockchain rails, and BlackRock CEO Larry Fink dedicated his entire 2026 annual letter to this infrastructure shift. Blockchain analyst Andy Howard is calling this asset 'Digital Oil' - and says institutional buyers are already positioned. | | Get the name, the ticker, and exactly how to buy it |
|
Retail/Wholesale | |
Despite hitting all-time highs last year as one of the best stocks to own during a recession, Dollar Tree Inc (NASDAQ: DLTR) has been on the defensive since the summer. Until this past August, their shares had held an almost unmatched track record of rallying before, during, and after the pandemic... Read the Full Story |
|
Medical | |
Abbott Laboratories (NYSE: ABT) share price has trended lower for nearly 2 years, but that trend is over. The impact of COVID on sales and the post-COVID letdown were cause enough for the market to sell, but not now; the market is oversold and overextended with normalization at hand. Normalization... Read the Full Story |
|
From Our Partners | | See the Signals Most Traders Miss
We monitor subtle shifts in order flow, volume patterns, and early trend behavior.
Stock News Trends highlights moves long before they hit mainstream screens. | | Join Free — Start Tracking Early Market Data |
|
Technology | |
Texas Instruments (NASDAQ: TXN) shares are down 25% from their pandemic highs, which no investors wish to see. However, Texas Instruments is a buy-and-hold-forever stock, so the 25% discount is good news for investors. Buy-and-hold forever stocks are blue chip names that pay dividends, have reliab... Read the Full Story |
|
Medical | |
Plenty of businesses, such as PepsiCo Inc. (NYSE: PEP) and Walmart Inc. (NYSE: WMT), have been under the microscope on fears of potential earnings decreases due to growing use of products like Novo Nordisk A/S' (NYSE: NVO) Ozempic, and similar drugs made by Eli Lilly & Co. (NYSE: LLY).
While... Read the Full Story |
|
From Our Partners | | With OpenAI and Anthropic moving closer to the IPO spotlight, AI excitement could spill into several public-market sectors this summer - and most investors may chase the obvious names too late.
A free report identifies 7 stocks positioned around themes that could matter most this summer: AI infrastructure, energy demand, travel, entertainment, home improvement, and more. Built for a market where leadership may rotate quickly. | | Download 7 Best Stocks to Own in Summer 2026 for free |
|
Technology | |
Will tightened restrictions on U.S. companies selling AI chips to China mean companies like Nvidia Corp. (NASDAQ: NVDA) will see their stocks tumble?
Despite working through a correction that began in early September, Nvidia remains the best performer in the S&P 500 this year, propelled by le... Read the Full Story |
|
Consumer Staples | |
The consumer staples sector, known for its stability and essential role in daily life, represents companies producing household goods like food, beverages, and personal care products.
The industry is characterized by its resilience, stability, and inelastic demand. In times of economic uncertain... Read the Full Story |
|
Auto/Tires/Trucks | |
By now, most market participants are aware of the UAW (United Auto Workers) union strikes, which pose a significant risk to domestic auto manufacturers and their profitability. That is about as far as the soundbite goes, but you are no ordinary investor, so you go one step further.
Realizing the ... Read the Full Story |
|
Finance | |
There are bubbles, and then there are bubbles; some associate the recent hype in Airbnb (NASDAQ: ABNB) with a significant mispricing opportunity, shining a light on traditional hotel platforms and long-standing brand names.
Sure, Airbnb offers a unique experience and flexibility, but that only go... Read the Full Story |
|
Aerospace | |
Escalating global tension and international conflict is good for the military industry and stocks like Lockheed Martin (NYSE: LMT). The conflict in Ukraine and the new war in Israel have governments worldwide replacing and ramping up stockpiles of material and ammunition, which is clearly seen in ... Read the Full Story |
|
Thursday's Early Bird Stock Of The Day Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics, and personalized patient data from electronic health record systems to generate a unique patient risk score. Its products are used in kidney disease diagnosis and prognosis, clinical care, patient stratification for drug clinical trials, and drug target discovery. Renalytix Plc has a license agreement with Mount Sinai Health System to develop and commercialize licensed products in connection with the application of artificial intelligence for the diagnosis of kidney disease; and Joslin Diabetes Center, Inc. for developing and commercializing products for diagnosing and predicting kidney disease using biomarkers. The company also has a partnership agreement with Atrium Health, Wake Forest Baptist Health, and Wake Forest School of Medicine to implement an advanced clinical care model designed to improve kidney health and reduce kidney disease progression and kidney failure. The company was formerly known as Renalytix AI plc and changed its name to Renalytix Plc in June 2021. Renalytix Plc was incorporated in 2018 and is based in New York, New York. | | View Today's Stock Pick |
|
